Getinge reports good organic growth in Q2 2026
Sales grew 4.6% organically, adjusted EBITA margin 17.6%, and free cash flow improved.
See the latest news and media coverage for Getinge. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology and life sciences solutions company
getinge.comLast updated
In short: Getinge reported strong organic growth in Q2 2026 and secured a $36 million U.S. tariff refund after a Supreme Court ruling.
Sales grew 4.6% organically, adjusted EBITA margin 17.6%, and free cash flow improved.
The combined entity accelerates innovation in transplant care, launching new products and entering new markets.
The MOHKI clinic, equipped with Getinge products, has treated over 70 children with congenital heart defects, including pioneering open-heart and TGA surgeries.
A jury found no infringement of Maquet's heart pump patents, with no financial impact.
AQR Capital becomes new public short seller in Getinge AQR Capital Management is also the only public short seller in the company. However, a total of 3.37 percent of the capital...
In the wake of the medical technology company Getinge's report for the second quarter of 2026, ABG Sundal Collier assesses that the profit profile has improved at the same time...
Investing.com -- UBS initiated coverage of Getinge AB with a Neutral rating and a price target of 255 Swedish crowns, saying the medical equipment maker’s...
The Stockholm Stock Exchange starts the Monday with a minor decline. At the company level, medical technology company Getinge falls after Nordea lowers its recommendation...
Track Getinge and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Getinge and other trending companies.